4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001415889-20-000880
CHIEF EXECUTIVE OFFICER bought 3,000 shares at $0.12 ($360)
From the SEC's structured data for this filing
Trades in this filing
Trieu Vuong · CHIEF EXECUTIVE OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-26 | Purchase : show line 1 in the form | +3,000 | $0.12 | $360 | 15,761,808 | D |
| Open-market purchases · 3,000 sh · avg $0.12 · $360 | ||||||
Loading xslF345X03/form4-03272020_020342.xml…